NCT02865382

Brief Summary

Optical Enhancement Technology might be superior to the conventional HD-WL in detecting colorectal adenomas

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2016

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 2, 2016

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 12, 2016

Completed
20 days until next milestone

Study Start

First participant enrolled

September 1, 2016

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2017

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2017

Completed
Last Updated

October 12, 2016

Status Verified

August 1, 2016

Enrollment Period

5 months

First QC Date

August 2, 2016

Last Update Submit

October 11, 2016

Conditions

Keywords

Adenoma detection rateOptical Enhancement TechnonogyColonoscopy

Outcome Measures

Primary Outcomes (1)

  • adenoma detection rate

    6 months

Study Arms (2)

Group A

ACTIVE COMPARATOR

white light was used for both insertion and withdrawal of the colonoscope

Procedure: white light was used for colonoscopy withdrawal

Group B

EXPERIMENTAL

Insertion to cecum was performed under white light and once the cecum was reached,the OE mode was swithed on during withdrawal of endoscope for complete colonic examination

Procedure: OE mode was used for colonoscopy withdrawal

Interventions

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients were selected if they presented for diagnostic colonoscopy for a variety of indications(eg positive fecal occult blood test, abdominal pain, diarrhoea,post-polypectomy surveillance).

You may not qualify if:

  • Patients with prior resection of the proximal colon, advanced colonic cancer, inflammatory bowel disease, or polyposis syndrome.
  • The cecum could not be intubated.
  • Inadequate bowel preparation (Aronchick Bowel Preparation Scale score poor or inadequate).
  • Biopsies were not available.
  • Unable to provide informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Gastroenterology, Qilu Hospital, Shandong University

Jinan, Shandong, 250012, China

Location

Related Publications (2)

  • Adler A, Pohl H, Papanikolaou IS, Abou-Rebyeh H, Schachschal G, Veltzke-Schlieker W, Khalifa AC, Setka E, Koch M, Wiedenmann B, Rosch T. A prospective randomised study on narrow-band imaging versus conventional colonoscopy for adenoma detection: does narrow-band imaging induce a learning effect? Gut. 2008 Jan;57(1):59-64. doi: 10.1136/gut.2007.123539. Epub 2007 Aug 6.

    PMID: 17681999BACKGROUND
  • Aminalai A, Rosch T, Aschenbeck J, Mayr M, Drossel R, Schroder A, Scheel M, Treytnar D, Gauger U, Stange G, Simon F, Adler A. Live image processing does not increase adenoma detection rate during colonoscopy: a randomized comparison between FICE and conventional imaging (Berlin Colonoscopy Project 5, BECOP-5). Am J Gastroenterol. 2010 Nov;105(11):2383-8. doi: 10.1038/ajg.2010.273. Epub 2010 Jul 13.

    PMID: 20628363BACKGROUND

MeSH Terms

Conditions

Colonic Polyps

Condition Hierarchy (Ancestors)

Intestinal PolypsPolypsPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Yanqing Li, MD, PhD

    Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan, Shandong Province, China

    STUDY DIRECTOR

Central Study Contacts

Yanqing Li, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 2, 2016

First Posted

August 12, 2016

Study Start

September 1, 2016

Primary Completion

February 1, 2017

Study Completion

March 1, 2017

Last Updated

October 12, 2016

Record last verified: 2016-08

Locations